Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multicentre, Randomized Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MaxioCel Compared With Aquacel Extra for the Management of Exuding Chronic Wounds

NCT05312762 is registered in ClinicalTrials.gov with Axio Biosolutions Pvt. Ltd. as lead sponsor.

NCT NCT05312762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05312762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multicentre, Randomized Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MaxioCel Compared With Aquacel Extra for the Management of Exuding Chronic Wounds
Lead sponsor
Axio Biosolutions Pvt. Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
April 27, 2022
Completion date
December 31, 2023
Enrollment
118 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

wound